Delivery Order SPE2DB25D3005-SPE2DB25FQFBG
Award Date
5/13/25
Potential Completion Date
5/14/25
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D1103|SPE2DB24FTDR3, was issued by the Defense Logistics Agency (DLA) to prime contractor Amerisourcebergen Drug Corp. The $28,418.85 Firm Fixed Price Delivery Order contract is for the supply of ZORTRESS 1 MG TABLET UD 60S, a pharmaceutical product. The contract has an ultimate completion date of January 10, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award, with ID SPE2DB22D3009|SPE2DB25FAT21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Zortress 1 mg tablet units, valued at $18,573.23. It is a Firm Fixed Price Delivery Order contract with a completion date of March 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,123.89 firm fixed-price delivery order is for the pharmaceutical product ZORTRESS 0.5 MG TABLET UD 60S, with a period of performance through July 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, with the ID SPE2DB22D3009|SPE2DB25FAN26, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Zortress 0.5 mg tablets, a pharmaceutical product, with a ceiling value of $15,074.60 and a completion date of January 10, 2025. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare...
This federal contract award, identified as SPE2DB20D3103|SPE2DB22FP7N6, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Zortress 0.5 mg tablet, a pharmaceutical product, with a ceiling value of $11,811.09 and a completion date of September 6, 2022. The contract is a delivery order, with a firm fixed-price pricing type, and does not have a set-aside designation, indicating...
This federal contract award, valued at $3,956.65, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is a $999,999,999 IDC running through November 2026. The contract is for the supply of pharmaceutical products, including the drug Zortress in 0.75 mg tablet form. As the award is not designated with a set-aside, it appears to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,184.09 Firm Fixed Price Delivery Order contract is for the supply of ZORTRESS 1 MG TABLET UD 60S, a pharmaceutical product. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DB20D2104|SPE2DB24FU27E, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,888.97 firm-fixed-price delivery order is for the supply of the medication ZORTRESS 0.5 MG TABLET UD 60S. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Zortress (everolimus) 0.25 mg tablets. The award is a delivery order with a firm fixed price of $3,385.45 and an ultimate completion date of August 1, 2024. The contract does not have a set-aside designation. As a large Indefinite Delivery Contract (IDC) holder with the DLA, AmerisourceBergen is a key supplier of a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,711.95 firm fixed-price delivery order is for the supply of Envarsus XR 4 mg tablets, a medication used in organ transplant patients. The contract has an ultimate completion date of May 30, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...